240 related articles for article (PubMed ID: 34722636)
1. Transcriptomic Analysis Identifies Complement Component 3 as a Potential Predictive Biomarker for Chemotherapy Resistance in Colorectal Cancer.
He XS; Zou SY; Yao JL; Yu W; Deng ZY; Wang JR; Gan WJ; Wan S; Yang XQ; Wu H
Front Mol Biosci; 2021; 8():763652. PubMed ID: 34722636
[No Abstract] [Full Text] [Related]
2. Hypermethylated and downregulated MEIS2 are involved in stemness properties and oxaliplatin-based chemotherapy resistance of colorectal cancer.
Wang X; Ghareeb WM; Zhang Y; Yu Q; Lu X; Huang Y; Huang S; Sun Y; Chi P
J Cell Physiol; 2019 Aug; 234(10):18180-18191. PubMed ID: 30859572
[TBL] [Abstract][Full Text] [Related]
3. FBXW4 Acts as a Protector of FOLFOX-Based Chemotherapy in Metastatic Colorectal Cancer Identified by Co-Expression Network Analysis.
Zhang Y; Sun L; Wang X; Sun Y; Chen Y; Xu M; Chi P; Lu X; Xu Z
Front Genet; 2020; 11():113. PubMed ID: 32218799
[TBL] [Abstract][Full Text] [Related]
4. Differential Expression Analysis Revealing CLCA1 to Be a Prognostic and Diagnostic Biomarker for Colorectal Cancer.
Wei FZ; Mei SW; Wang ZJ; Chen JN; Shen HY; Zhao FQ; Li J; Liu Z; Liu Q
Front Oncol; 2020; 10():573295. PubMed ID: 33251137
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and Predictive Role of Excision Repair Cross-complementation Group 1 and Thymidylate Synthase in Colorectal Carcinoma Patients Received FOLFOX Chemotherapy: An Immunohistochemical Study.
Badary DM; Elkabsh MM; Mady HH; Gabr A; Kroosh SS
Appl Immunohistochem Mol Morphol; 2020; 28(10):741-747. PubMed ID: 32118594
[TBL] [Abstract][Full Text] [Related]
6. Identification Hub Genes in Colorectal Cancer by Integrating Weighted Gene Co-Expression Network Analysis and Clinical Validation
Yuan Y; Chen J; Wang J; Xu M; Zhang Y; Sun P; Liang L
Front Oncol; 2020; 10():638. PubMed ID: 32426282
[TBL] [Abstract][Full Text] [Related]
7. Gene expression signature and response to the use of leucovorin, fluorouracil and oxaliplatin in colorectal cancer patients.
Watanabe T; Kobunai T; Yamamoto Y; Matsuda K; Ishihara S; Nozawa K; Iinuma H; Konishi T; Horie H; Ikeuchi H; Eshima K; Muto T
Clin Transl Oncol; 2011 Jun; 13(6):419-25. PubMed ID: 21680303
[TBL] [Abstract][Full Text] [Related]
8. Prognostic and predictive significance of long interspersed nucleotide element-1 methylation in advanced-stage colorectal cancer.
Kaneko M; Kotake M; Bando H; Yamada T; Takemura H; Minamoto T
BMC Cancer; 2016 Dec; 16(1):945. PubMed ID: 27955637
[TBL] [Abstract][Full Text] [Related]
9. Weighted gene co-expression network analysis for hub genes in colorectal cancer.
Xu Z; Wang J; Wang G
Pharmacol Rep; 2024 Feb; 76(1):140-153. PubMed ID: 38150140
[TBL] [Abstract][Full Text] [Related]
10. Effects of Proton Pump Inhibitors on FOLFOX and CapeOx Regimens in Colorectal Cancer.
Wong GG; Ha V; Chu MP; Dersch-Mills D; Ghosh S; Chambers CR; Sawyer MB
Clin Colorectal Cancer; 2019 Mar; 18(1):72-79. PubMed ID: 30551953
[TBL] [Abstract][Full Text] [Related]
11. Nuclear orphan receptor NR4A2 confers chemoresistance and predicts unfavorable prognosis of colorectal carcinoma patients who received postoperative chemotherapy.
Han Y; Cai H; Ma L; Ding Y; Tan X; Liu Y; Su T; Yu Y; Chang W; Zhang H; Fu C; Cao G
Eur J Cancer; 2013 Nov; 49(16):3420-30. PubMed ID: 23809767
[TBL] [Abstract][Full Text] [Related]
12. Weighted gene co-expression network analysis identified MYL9 and CNN1 are associated with recurrence in colorectal cancer.
Qiu X; Cheng SH; Xu F; Yin JW; Wang LY; Zhang XY
J Cancer; 2020; 11(8):2348-2359. PubMed ID: 32127961
[TBL] [Abstract][Full Text] [Related]
13. Demethylation and Overexpression of CSF2 are Involved in Immune Response, Chemotherapy Resistance, and Poor Prognosis in Colorectal Cancer.
Xu Z; Zhang Y; Xu M; Zheng X; Lin M; Pan J; Ye C; Deng Y; Jiang C; Lin Y; Lu X; Chi P
Onco Targets Ther; 2019; 12():11255-11269. PubMed ID: 31908491
[TBL] [Abstract][Full Text] [Related]
14. [Construction of artificial neural network model for predicting the efficacy of first-line FOLFOX chemotherapy for metastatic colorectal cancer].
Lin SM; Wang XJ; Huang SH; Xu ZB; Huang Y; Lu XR; Xu DB; Chi P
Zhonghua Zhong Liu Za Zhi; 2021 Feb; 43(2):202-206. PubMed ID: 33601485
[No Abstract] [Full Text] [Related]
15. Identification of LncRNAs Associated With FOLFOX Chemoresistance in mCRC and Construction of a Predictive Model.
Zhang Y; Xu M; Sun Y; Chen Y; Chi P; Xu Z; Lu X
Front Cell Dev Biol; 2020; 8():609832. PubMed ID: 33585448
[TBL] [Abstract][Full Text] [Related]
16. Identification of Hub Genes Associated With Sensitivity of 5-Fluorouracil Based Chemotherapy for Colorectal Cancer by Integrated Bioinformatics Analysis.
Wang Y; Wei Q; Chen Y; Long S; Yao Y; Fu K
Front Oncol; 2021; 11():604315. PubMed ID: 33912443
[TBL] [Abstract][Full Text] [Related]
17. In silico identification of the specific pathways in each stage of colorectal cancer and the association of their top genes with drug resistance and sensitivity.
Hashemi R; Peymani M; Ghaedi K; Saffar H
Med Oncol; 2022 Feb; 39(5):57. PubMed ID: 35150347
[TBL] [Abstract][Full Text] [Related]
18. Qualitative transcriptional signature for predicting pathological response of colorectal cancer to FOLFOX therapy.
He J; Cheng J; Guan Q; Yan H; Li Y; Zhao W; Guo Z; Wang X
Cancer Sci; 2020 Jan; 111(1):253-265. PubMed ID: 31785020
[TBL] [Abstract][Full Text] [Related]
19. Ano1 is a Prognostic Biomarker That is Correlated with Immune Infiltration in Colorectal Cancer.
Chen J; Wang H; Peng F; Qiao H; Liu L; Wang L; Shang B
Int J Gen Med; 2022; 15():1547-1564. PubMed ID: 35210827
[TBL] [Abstract][Full Text] [Related]
20. Identification of candidate genes and miRNAs for sensitizing resistant colorectal cancer cells to oxaliplatin and irinotecan.
Poorebrahim M; Sadeghi S; Ghanbarian M; Kalhor H; Mehrtash A; Teimoori-Toolabi L
Cancer Chemother Pharmacol; 2020 Jan; 85(1):153-171. PubMed ID: 31781855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
